Vulvovaginal candidiasis is an inflammation of the vaginal area and involves the vulva caused by Candida yeast infection. Approximately 75% of women have at least one episode of vulvovaginal candidiasis during reproductive age and half have had two or more episodes. Risk factors for vulvovaginal candidiasis include pregnancy, use of contraception, estrogen therapy, diabetes mellitus, use of immunosuppression, and systemic antibiotics. Case Report: We report a case of a woman, 33 years old, with complaints of vaginal discharge since 2 months ago. The patient was given a vaginal swab and a complete vaginal swab laboratory examination was performed to find the cause of vaginal discharge. The patient has been suffering from Systemic Lupus Erytomatosus (SLE) since 4 years ago and has been taking Hydroxychloroquine 400 mg/day for 1 year, Methylprednisolone 4 mg/day and antihistamines to treat itching in the patient's body. The patient had experienced vaginal discharge three years ago. From the results of direct vaginal swab examination, yeast cells and pseudohyphae were obtained, followed by a culture that yielded the growth of yeast colonies. From the results of the resistance test to fungal drugs, the results were sensitive to the antifungals Itrakonazol, Ketokonazol, Flukonazol, and Nystatin.
CITATION STYLE
Mawahdah, R., Dwi Ananingsih, P., Wahdini, S., Adawiyah, R., & Meutia, A. P. (2022). KANDIDIASIS VULVOVAGINALIS PADA PASIEN SLE. Indonesian Journal for Health Sciences, 6(2), 65–71. https://doi.org/10.24269/ijhs.v6i2.4934
Mendeley helps you to discover research relevant for your work.